Company Monitoring Page for Daiichi-Sankyo

latest headlines for company on cafepharma

Roche nets FDA approval for HER2-low breast cancer test paired with AstraZeneca-Daiichi's Enhertu
Fierce Biotech
Wed, 10/5/22 - 07:07 pm
Tags:
Roche, FDA, diagnostics, Medtech, HER2-low breast cancer, Enhertu, AstraZeneca, Daiichi Sankyo
Daiichi Sankyo's Ezharmia Becomes First EZH1/2 Inhibitor for Blood Cancer
BioSpace
Mon, 09/26/22 - 11:32 pm
Tags:
Daiichi Sankyo, Japan, Ezharmia, relapsed or refractory adult T-cell leukemia/lymphoma
ESMO: Daiichi dazzles in lung cancer to dial up hopes for next ADC
Fierce Biotech
Mon, 09/12/22 - 10:43 am
Tags:
ESMO, Daiichi Sankyo, DS-7300, small cell lung cancer
Seagen loses arbitration case to Daiichi Sankyo over cancer drug technology
BioPharma Dive
Sun, 08/14/22 - 10:50 pm
Tags:
Seagen, legal, arbitration, Daiichi Sankyo
FDA approves AstraZeneca, Daiichi drug in breast cancer first
BioPharma Dive
Sun, 08/7/22 - 11:24 pm
Tags:
AstraZeneca, Daiichi Sankyo, breast cancer, Enhertu, FDA, HER2-low breast cancer
AstraZeneca wins two recommendations, one priority review
Morningstar
Mon, 07/25/22 - 10:54 am
Tags:
AstraZeneca, Europe, Daiichi Sankyo, Enhertu, breast cancer, Ultomiris, Tezspire
Daiichi Sankyo willfully infringed Seagen patent in creating Enhertu, court rules
Fierce Pharma
Wed, 07/20/22 - 09:58 am
Tags:
Daiichi Sankyo, Seagen, Enhertu, patents, legal
EHA: Survival data sets Daiichi Sankyo’s quizartinib back on track
Pharmaforum
Mon, 06/13/22 - 10:44 am
Tags:
Daiichi Sankyo, EHA, quizartinib, clinical trials, acute myeloid leukemia
ASCO22: Enhertu aces key HER2-low test in breast cancer
Pharmaforum
Mon, 06/6/22 - 09:43 am
Tags:
ASCO 2022, AstraZeneca, Daiichi Sankyo, Enhertu, HER2-low breast cancer, breast cancer
Former AstraZeneca exec committed insider trading on landmark 2019 Enhertu deal, SEC alleges
Endpoints
Tue, 05/31/22 - 10:39 am
Tags:
AstraZeneca, insider trading, SEC, Enhertu, Daiichi Sankyo
The 12 Top Biotech Companies Hiring Now
BioSpace
Tue, 05/10/22 - 10:26 pm
Tags:
biotech, life sciences, hirings, Regeneron, Pfizer, Amgen, AbbVie, Moderna Therapeutics, CSL Behring, Waters Corporation, Daiichi Sankyo, Gilead Sciences, Grail, Emergent BioSolutions, resilience
FDA Approves AstraZeneca, Daiichi Sankyo’s ENHERTU in Breast Cancer
Contract Pharma
Thu, 05/5/22 - 10:40 am
Tags:
AstraZeneca, Daiichi Sankyo, Enhertu, FDA, HER2+ breast cancer, breast cancer
FDA starts speedy review of Enhertu in lung cancer
Pharmaforum
Tue, 04/19/22 - 10:54 am
Tags:
AstraZeneca, Daiichi Sankyo, FDA, non-small cell lung cancer, Enhertu
Seagen scores $41.8M in Enhertu patent case against Daiichi Sankyo
Fierce Pharma
Mon, 04/11/22 - 11:00 am
Tags:
Seagen, Daiichi Sankyo, patents, breast cancer, Enhertu
Big day for AZ, Daiichi as Enhertu aces HER2-low breast cancer trial
Pharmaforum
Mon, 02/21/22 - 10:35 am
Tags:
AstraZeneca, Daiichi Sankyo, Enhertu, clinical trials, HER2-low breast cancer, breast cancer
Daiichi makes play for share of Japan’s COVID booster market
Pharmaforum
Mon, 01/31/22 - 10:49 am
Tags:
Daiichi Sankyo, COVID-19, vaccines, MRNA, Japan, DS-5670
Daiichi Sankyo shuts down Plexxikon subsidiary to streamline Enhertu, ADC development
Endpoints
Wed, 01/12/22 - 11:26 pm
Tags:
Daiichi Sankyo, Plexxikon, Enhertu
Biopharma developments over the Christmas period
EP Vantage
Mon, 01/3/22 - 10:26 am
Tags:
Alnylam Pharmaceuticals, Bio-Thera Solutions, BioArctic, Biogen, BridgeBio Pharma, Daiichi Sankyo, Eisai, JNJ, Madrigal Pharmaceuticals, Merck, Sutro BioPharma, Tasly Pharmaceutical Group
FDA gives Daiichi Sankyo’s HER3 drug a breakthrough tag
Pharmaforum
Thu, 12/23/21 - 11:53 am
Tags:
Daiichi Sankyo, FDA, antibody-drug conjugate, lung cancer, HER3, patritumab deruxtecan
AZ, Daiichi take aim at Gilead in triple-negative breast cancer
Pharmaforum
Wed, 12/8/21 - 10:37 am
Tags:
AstraZeneca, Daiichi Sankyo, Gilead Sciences, Trodelvy, triple negative breast cancer, Dato-DXd

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.